AGEX THERAPEUTICS INC (AGE)

US00848H2076 - Common Stock

11.1  -1.5 (-11.9%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2023-9-30)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
100.00K30.00K140.00K360.00K1.73M
Minority Interest Expense
70.00K60.00K0.0010.00K230.00K
Cost Of Goods
40.00K10.00K20.00K30.00K240.00K
Gross Profit
50.00K20.00K130.00K340.00K1.48M
Operating Expenses
8.24M7.00M8.17M10.43M14.05M
Research and Development
640.00K890.00K1.33M3.58M5.90M
Selling, General, and Administrative Expenses
7.47M5.97M6.71M6.72M8.14M
Operating Income
-8.19M-6.98M-8.04M-10.10M-12.56M
Interest Income/Expense
-5.91M-3.34M-1.10M-400.00K30.00K
Other Income/Expense
-30.00K-210.00K450.00K110.00K290.00K
Non Recurring Items
N/A0.00110.00K0.00N/A
Income Before Taxes
-14.12M-10.52M-8.58M-10.40M-12.24M
Income Tax
N/AN/A0.00-150.00K150.00K
Net Income
-14.05M-10.46M-8.68M-10.87M-12.15M
EBITDA
-8.06M-6.85M-7.91M-8.84M-11.91M
 
Per Share Data
EPS Diluted Total Ops
-0.37-0.28-0.23-0.27-0.33
 
Statistics
Gross Profit Margin
50.00%66.67%92.86%94.44%85.55%
Profit Margin
-14050.00%-34866.67%-6200.00%-3019.44%-702.31%
Operating Profit Margin
-8190.00%-23266.67%-5742.86%-2805.56%-726.01%

All data in USD

Charts